OverviewChartNewsTraderScreen

JP Morgan Call 790 LLY 16.08.2024/  DE000JT6DK78  /

EUWAX
8/9/2024  3:54:49 PM Chg.- Bid11:12:11 AM Ask11:12:11 AM Underlying Strike price Expiration date Option type
0.940EUR - 0.980
Bid Size: 15,000		 -
Ask Size: -		 Eli Lilly and Co 790.00 USD 8/16/2024 Call
TeleTrader 8/8 US opens higher with data, earnings in focus
TeleTrader 8/8 Eli Lilly's Q2 revenue jumps 36% to $11.3B
TeleTrader 7/8 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 7/2 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 7/1 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 6/28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 6/25 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 6/21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 6/17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 6/17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 6/14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 6/10 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 6/10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 6/6 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 6/5 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 6/3 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 5/30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 5/24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 5/24 Eli Lilly to reveal $5.3B production boost
TeleTrader 5/21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 5/16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 5/16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 5/13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update